BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7108214)

  • 1. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
    Circolo A; Borsos T
    J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of binding of C3 to IgG antibodies during the activation of the classical complement pathway on the red cell.
    Circolo A; Borsos T
    Mol Immunol; 1984 Mar; 21(3):191-5. PubMed ID: 6717444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G; van Es LA; Daha MR
    Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
    Ejzemberg R; Borsos T
    J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP; Cooper NR
    J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the human classical complement pathway by a mouse monoclonal hybrid IgG1-2a monovalent anti-TNP antibody bound to TNP-conjugated cells.
    Couderc J; Kazatchkine MD; Ventura M; Duc HT; Maillet F; Thobie N; Liacopoulos P
    J Immunol; 1985 Jan; 134(1):486-91. PubMed ID: 3917282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in human lymphoid germinal centres.
    Zwirner J; Felber E; Schmidt P; Riethmüller G; Feucht HE
    Immunology; 1989 Feb; 66(2):270-7. PubMed ID: 2925226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
    Lambre CR; Thibon M; Le Maho S; Di Bella G
    Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    Borsos T; Circolo A
    J Immunol; 1985 Jan; 134(1):492-4. PubMed ID: 3964818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
    Betz SJ; Page N; Estrade C; Isliker H
    J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA; Steiger G; Schapira M
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical pathway of complement activation in mammalian kidneys.
    Zwirner J; Felber E; Burger R; Bitter-Suermann D; Riethmüller G; Feucht HE
    Immunology; 1993 Oct; 80(2):162-7. PubMed ID: 8262545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the classical pathway of human complement by a human monoclonal IgE, IgE(DES).
    Saint-Remy JM; Magnusson CG; Masson PL
    J Immunol; 1983 Mar; 130(3):1341-4. PubMed ID: 6822738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.